Benitec Biopharma Inc.

Axovant Sciences Ltd. declared it was closing a chapter on its small molecule efforts after the failure of the 5-H2A receptor agonist nelotanserin in Lewy body dementias (LBD), as it continues to foc

In a summer slowdown, biopharmaceutical start-up fundraising declined 27% in the third quarter of 2018, but Gossamer Bio Inc. and Orchard Therapeutics Ltd. brought in large venture capital rounds

The second quarter was a record-breaking period with China-focused biopharma start-ups and others raising hundreds of millions of dollars in venture capital. Both the amount of money raised and the nu

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in